Fund profile
Dolby Family Ventures
San Francisco, United States
Leading
About
Dolby Family Ventures is an early-stage venture capital firm that focuses on building technology companies. Established in honor of Ray Dolby, the firm aims to support innovators at the seed stage of development, partnering with strong investment syndicates to bring breakthrough technologies to market. Dolby Family Ventures has a diverse portfolio that includes companies in sectors such as biotech, healthcare IT, cybersecurity, and sustainability. Key investments include Athira Pharma, which focuses on neurodegenerative disease therapies, and Hyperfine Research, known for its portable MRI systems. Other notable investments are Switch Therapeutics, which develops RNAi therapies, and MedCrypt, specializing in healthcare cybersecurity. The firm has also seen successful exits, such as Basis Science, acquired by Intel, and goBalto, acquired by Oracle. Dolby Family Ventures works actively with entrepreneurs, offering support in operational finance, strategy, and board development, ensuring that the startups they invest in have the best chances of success. They are committed to fostering innovation that solves significant global challenges.
Details
Highlights
$2.3M
Historical average check
$65M
Historical max check
May 2024
Last investment date
119
Investments
Pharma
Healthtech & Wellness
Transportation & Mobility
Agritech & Farming
Legal & Professional services
Security & Privacy
Natural Resources
Biotech
Software & Apps
Consumer Goods & Electronics
Hardware. Robotics & IoT
Other
Showing 0 lists
Contacts
Lists that include this fund